CONTEXT: Pain, depression, and fatigue are common symptoms in cancer populations. They often coexist and have been suggested as a specific symptom cluster. Systemic inflammation (SI) may be a possible common mechanism. OBJECTIVE: This study examined whether pain, depression, and fatigue exist as a symptom cluster in advanced cancer patients with cachexia and might be related to the presence of SI. METHODS: Secondary data analysis was undertaken of two clinical trials in patients with cancer cachexia (n = 654). Pain, depression, and fatigue were assessed using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30. Plasma C-reactive protein (CRP) was measured as a marker of SI in a subgroup (n = 436). Multivariate analysis and a series of regression analyses were undertaken relating pain, depression, fatigue, and CRP. RESULTS: Pain, depression, and fatigue clustered, with between two and four times as many patients having all three symptoms as would be expected if the symptoms only coexist by chance (P < 0.001). CRP was not related to the symptom cluster. There was a strong relationship between the pattern of symptoms and physical functioning (P < 0.001). CONCLUSION: Pain, depression, and fatigue is an identifiable symptom cluster in a cohort of cachexic cancer patients and is associated with reduced physical functioning.
CONTEXT: Pain, depression, and fatigue are common symptoms in cancer populations. They often coexist and have been suggested as a specific symptom cluster. Systemic inflammation (SI) may be a possible common mechanism. OBJECTIVE: This study examined whether pain, depression, and fatigue exist as a symptom cluster in advanced cancerpatients with cachexia and might be related to the presence of SI. METHODS: Secondary data analysis was undertaken of two clinical trials in patients with cancer cachexia (n = 654). Pain, depression, and fatigue were assessed using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30. Plasma C-reactive protein (CRP) was measured as a marker of SI in a subgroup (n = 436). Multivariate analysis and a series of regression analyses were undertaken relating pain, depression, fatigue, and CRP. RESULTS:Pain, depression, and fatigue clustered, with between two and four times as many patients having all three symptoms as would be expected if the symptoms only coexist by chance (P < 0.001). CRP was not related to the symptom cluster. There was a strong relationship between the pattern of symptoms and physical functioning (P < 0.001). CONCLUSION:Pain, depression, and fatigue is an identifiable symptom cluster in a cohort of cachexic cancerpatients and is associated with reduced physical functioning.
Authors: Francisco Álvarez-Salvago; Noelia Galiano-Castillo; Manuel Arroyo-Morales; Mayra Cruz-Fernández; Mario Lozano-Lozano; Irene Cantarero-Villanueva Journal: Support Care Cancer Date: 2018-05-05 Impact factor: 3.603
Authors: Lisa M Jaremka; Rebecca R Andridge; Christopher P Fagundes; Catherine M Alfano; Stephen P Povoski; Adele M Lipari; Doreen M Agnese; Mark W Arnold; William B Farrar; Lisa D Yee; William E Carson; Tanios Bekaii-Saab; Edward W Martin; Carl R Schmidt; Janice K Kiecolt-Glaser Journal: Health Psychol Date: 2013-08-19 Impact factor: 4.267
Authors: Brandon N VanderVeen; Dennis K Fix; Ryan N Montalvo; Brittany R Counts; Ashley J Smuder; E Angela Murphy; Ho-Jin Koh; James A Carson Journal: Exp Physiol Date: 2019-01-15 Impact factor: 2.969
Authors: Christine Miaskowski; Andrea Barsevick; Ann Berger; Rocco Casagrande; Patricia A Grady; Paul Jacobsen; Jean Kutner; Donald Patrick; Lani Zimmerman; Canhua Xiao; Martha Matocha; Sue Marden Journal: J Natl Cancer Inst Date: 2017-01-24 Impact factor: 13.506
Authors: Jung Hye Kwon; Sung Yong Oh; Gary Chisholm; Jung-Ae Lee; Jae Jin Lee; Keon Woo Park; Seung-Hyun Nam; Hun Ho Song; Keehyun Lee; Dae Young Zang; Ho Young Kim; Dae Ro Choi; Hyo Jung Kim; Jung Han Kim; Joo Young Jung; Geundoo Jang; Hyeong Su Kim; Ji Yun Won; Eduardo Bruera Journal: Support Care Cancer Date: 2012-11-15 Impact factor: 3.603